These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2458485)

  • 1. Antiviral effect of lymphokine-activated killer cells: characterization of effector cells mediating prophylaxis.
    Bukowski JF; Yang H; Welsh RM
    J Virol; 1988 Oct; 62(10):3642-8. PubMed ID: 2458485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection.
    McIntyre KW; Welsh RM
    J Exp Med; 1986 Nov; 164(5):1667-81. PubMed ID: 3490535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of large granular T lymphocytes in vivo during viral infection.
    Biron CA; Natuk RJ; Welsh RM
    J Immunol; 1986 Mar; 136(6):2280-6. PubMed ID: 3485144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.
    Bukowski JF; Warner JF; Dennert G; Welsh RM
    J Exp Med; 1985 Jan; 161(1):40-52. PubMed ID: 2981954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function.
    Welsh RM; Brubaker JO; Vargas-Cortes M; O'Donnell CL
    J Exp Med; 1991 May; 173(5):1053-63. PubMed ID: 1850779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer (NK) cell subsets in the mouse. NK-1.1+/LGL-1+ cells restricted to lysing NK targets, whereas NK-1.1+/LGL-1- cells generate lymphokine-activated killer cells.
    Mason LH; Mathieson BJ; Ortaldo JR
    J Immunol; 1990 Jul; 145(2):751-9. PubMed ID: 2365999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
    Bukowski JF; Biron CA; Welsh RM
    J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
    J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
    J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.
    Bukowski JF; Woda BA; Habu S; Okumura K; Welsh RM
    J Immunol; 1983 Sep; 131(3):1531-8. PubMed ID: 6309965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
    Gunji Y; Vujanovic NL; Hiserodt JC; Herberman RB; Gorelik E
    J Immunol; 1989 Mar; 142(5):1748-54. PubMed ID: 2783950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication.
    Natuk RJ; Welsh RM
    J Immunol; 1987 Feb; 138(3):877-83. PubMed ID: 3027167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ; Krosnick JA; Rosenberg SA
    J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.
    Tay CH; Yu LY; Kumar V; Mason L; Ortaldo JR; Welsh RM
    J Immunol; 1999 Jan; 162(2):718-26. PubMed ID: 9916691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction.
    Welsh RM
    J Exp Med; 1978 Jul; 148(1):163-81. PubMed ID: 307587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.